Clinical Trial Update: Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Children [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating an autologous dermo-epidermal skin substitute for treating burns in children is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burn Injuries

Drugs mentioned

• Autologous dermo-epidermal skin substitute

Snippet

Sponsor: CUTISS AG | Conditions: Burns | Phase 2 | Status: ACTIVE_NOT_RECRUITING